These results document that PGE2 acts as a potent promoter of NSCLC growth and progression by inducing EGFR nuclear translocation and by increasing the expression of nuclear EGFR target genes involved in cell proliferation, cell cycle progression and inflammation. Here, EGFR is linked to non-small cell lung carcinoma.